首页> 外文期刊>癌と化学療法 >Clinical evaluation of lung cancer patients with only best supportive care
【24h】

Clinical evaluation of lung cancer patients with only best supportive care

机译:仅提供最佳支持治疗的肺癌患者的临床评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Eighteen cases with only symptomatically treated lung cancer admitted to our hospital from May 2002 to October 2006 were retrospectively investigated clinically. The patients consisted of 10 males and 8 females, aged 50-9 8 years old (mean age 78.1 yo). Clinical stage distribution revealed a higher incidence in the advanced stages. The performance status according to the ECOG classification was predominantly grade 2-4. The average survival time was 5.9 4 months. The cell type was the major prognosticator followed by clinical stage and age. There was a tendency to die early in any case that had a poor whole-body state, such as weight reduction and a feeling of whole body fatigue. There was a tendency for the at home period to be short in cases that required control of pleural effusion, and the survival period was short.
机译:回顾性分析2002年5月至2006年10月我院收治的18例经对症治疗的肺癌患者的临床资料。患者包括10例男性和8例女性,年龄50-9 8岁(平均年龄78.1岁)。临床阶段分布显示晚期阶段发生率更高。根据ECOG分类的绩效状态主要为2-4级。平均生存时间为5.9±4个月。细胞类型是主要的预后因素,其次是临床阶段和年龄。体重减轻和全身疲劳感等全身状态较差的情况下,都有早死的趋势。在需要控制胸腔积液的情况下,有一个在家时期短的趋势,并且生存期短。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号